News Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
0.6 ^USD	-0.17%		-11.69%	-49.15%

14/05	Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04	Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update	15/05	AQ
Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	26/04	MT
Vincerx Pharma Prices Public Offering of Shares, Warrants	26/04	MT
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants	26/04	AQ
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants	26/04	AQ
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09/04	MT
Top Premarket Decliners	09/04	MT
Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell	09/04	MT
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024	09/04	AQ
Vincerx Pharma, Inc. Presents Positive Preliminary Phase 1 Data for Vip236 and Updates on Pipeline Progress At the American Association for Cancer Research Annual Meeting 2024	09/04	CI
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	01/04	AQ
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update	30/03	AQ
Vincerx Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03	CI
North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024	06/03	AQ
Vincerx Pharma Shares Jump After Results of Blood Cancer Treatment Trial	09/01	MT
Top Premarket Gainers	08/01	MT
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	08/01	AQ
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma	08/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Summary

Filters